Ezaki Glico Co., Ltd. (TSE:2206) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Ezaki Glico Co., Ltd. (TSE:2206) shareholders are probably feeling a little disappointed, since its shares fell 3.5% to JP¥4,636 in the week after its latest first-quarter results. Results look mixed - while revenue fell marginally short of analyst estimates at JP¥77b, statutory earnings were in line with expectations, at JP¥128 per share. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

Our free stock report includes 3 warning signs investors should be aware of before investing in Ezaki Glico. Read for free now.

Following the latest results, Ezaki Glico's twin analysts are now forecasting revenues of JP¥350.3b in 2025. This would be a modest 6.3% improvement in revenue compared to the last 12 months. Per-share earnings are expected to shoot up 107% to JP¥177. Yet prior to the latest earnings, the analysts had been anticipated revenues of JP¥351.7b and earnings per share (EPS) of JP¥180 in 2025. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

See our latest analysis for Ezaki Glico

There were no changes to revenue or earnings estimates or the price target of JP¥3,750, suggesting that the company has met expectations in its recent result.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. The analysts are definitely expecting Ezaki Glico's growth to accelerate, with the forecast 8.5% annualised growth to the end of 2025 ranking favourably alongside historical growth of 2.0% per annum over the past three years. Compare this with other companies in the same industry, which are forecast to grow their revenue 3.2% annually. Factoring in the forecast acceleration in revenue, it's pretty clear that Ezaki Glico is expected to grow much faster than its industry.

The Bottom Line

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that in mind, we wouldn't be too quick to come to a conclusion on Ezaki Glico. Long-term earnings power is much more important than next year's profits. We have analyst estimates for Ezaki Glico going out as far as 2027, and you can see them free on our platform here.

It is also worth noting that we have found 3 warning signs for Ezaki Glico (1 is concerning!) that you need to take into consideration.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.